INSM — Insmed Incorporated Share News
0.000.00%
Last trade - 00:00- $21.67bn
- $21.23bn
- $606.42m
Brief: Insmed Incorporated - Launches Four Pivotal Phase 3 Studies For TPIP In Pulmonary Diseases
U.S. STOCKS ON THE MOVE-Nike, Synopsys, Intel
Insmed CFO Sara Bonstein steps down; shares fall
U.S. STOCKS ON THE MOVE- Cenovus Energy, TeraWulf, Alector
Insmed shares slip as CFO Sara Bonstein steps down
Democratic ETF gains outpace MAGA fund ahead of midterm polls
U.S. STOCKS ON THE MOVE-Insmed, Marvell, Meta
US STOCKS ON THE MOVE-Meta, Marvell Technology, Insmed
Insmed rises on FDA priority review for lung disease drug
Brief: FDA Grants Priority Review To Insmed's SNDA For Arikayce For Treatment Of Mac Lung Disease With PDUFA Target Action Date Set For January 28, 2027
U.S. STOCKS ON THE MOVE-Braveheart Bio, Paysign, Hertz Global
U.S. STOCKS ON THE MOVE-Ralph Lauren, Sempra, Parker-Hannifin, Lincoln International
Insmed Inc reports results for the quarter ended June 30 - Earnings Summary
U.S. STOCKS ON THE MOVE- MACOM Technology , Becton Dickinson, Centrus Energy
Insmed surges after Q2 revenue beat
Insmed Q2 revenue beats estimates
Astera Labs, CoreWeave and others rise after Nasdaq-100 inclusion
U.S. RESEARCH ROUNDUP-Arthur J. Gallagher & Co, Datadog, Oracle
U.S. RESEARCH ROUNDUP- Adobe, Allstate, Teleflex